Patents by Inventor Alexander Goldshmidt

Alexander Goldshmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12110495
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: October 8, 2024
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Publication number: 20240254501
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Application
    Filed: February 22, 2024
    Publication date: August 1, 2024
    Applicant: Monsanto Technology LLC
    Inventors: Brent BROWER-TOLAND, Shunhong DAI, Karen GABBERT, Alexander GOLDSHMIDT, Miya HOWELL, Brad MCDILL, Dan OVADYA, Beth SAVIDGE, Vijay SHARMA
  • Publication number: 20230159946
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Application
    Filed: November 28, 2022
    Publication date: May 25, 2023
    Applicant: Monsanto Technology LLC
    Inventors: Brent BROWER-TOLAND, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad Mcdill, Dan Ovadya, Beth Savidge, Vijay Sharma
  • Publication number: 20230110884
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Application
    Filed: June 22, 2022
    Publication date: April 13, 2023
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards Allen, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Silvalinganna MANJUNATH, Anil NEELAM, Linda RYMARQUIS, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG
  • Patent number: 11555201
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: January 17, 2023
    Assignee: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya Howell, Brad McDill, Dan Ovadya, Beth Savidge, Vijay Sharma
  • Publication number: 20220364108
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Application
    Filed: April 5, 2022
    Publication date: November 17, 2022
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Sivalinganna MANJUNATH, Anil NEELAM, Linda RYMARQUIS, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG
  • Patent number: 11414670
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: August 16, 2022
    Assignee: Monsanto Technology LLC
    Inventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang, Sivalinganna Manjunath, Linda Rymarquis
  • Patent number: 11319550
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: May 3, 2022
    Assignee: Monsanto Technology LLC
    Inventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang, Sivalinganna Manjunath, Linda Rymarquis
  • Publication number: 20220090105
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Application
    Filed: December 7, 2021
    Publication date: March 24, 2022
    Applicant: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Patent number: 11225671
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: January 18, 2022
    Assignee: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Publication number: 20200362360
    Abstract: This disclosure provides recombinant DNA constructs and modified or transgenic plants having enhanced traits such as increased yield, increased nitrogen use efficiency, and enhanced drought tolerance or water use efficiency. Modified or transgenic plants may include field crops as well as plant propagules, plant parts and progeny of such modified or transgenic plants. Methods of making and using such modified or transgenic plants are also provided, as are methods of producing seed from such modified or transgenic plants, growing such seed, and selecting progeny plants with enhanced traits. Further disclosed are modified or transgenic plants with altered phenotypes or traits which are useful for screening and selecting transgenic events, edits or mutations with a desired enhanced trait.
    Type: Application
    Filed: November 21, 2018
    Publication date: November 19, 2020
    Inventors: Robert M. Alba, Edwards M. Allen, Brent Brower-Toland, Molian Deng, Todd DeZwaan, Charles Dietrich, Alexander Goldshmidt, Cara L. Griffith, Miya D. Howell, Niranjani J. Iyer, Hongwu Jia, Saritha V. Kuriakose, Hong Li, Linda L. Lutfiyya, Anil Neelam, Shengzhi Pang, Mingsheng Peng, Monnanda Somaiah Rajani, Daniel Ruzicka, Daniel P. Schachtman, Vijay K. Sharma, Tyamagondlu V. Venkatesh, Huai Wang, Xiaoyun Wu, Nanfei Xu
  • Publication number: 20200248200
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Application
    Filed: April 13, 2020
    Publication date: August 6, 2020
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Anil NEELAM, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG, Sivalinganna MANJUNATH, Linda RYMARQUIS
  • Publication number: 20200248199
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Application
    Filed: April 13, 2020
    Publication date: August 6, 2020
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards M. ALLEN, Jayanand BODDU, Charles R. DIETRICH, Alexander GOLDSHMIDT, Miya HOWELL, Kevin R. KOSOLA, Anil NEELAM, Thomas L. SLEWINSKI, Tyamagondlu V. VENKATESH, Huai WANG, Sivalinganna MANJUNATH, Linda RYMARQUIS
  • Patent number: 10724047
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: July 28, 2020
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Sivalinganna Manjunath, Anil Neelam, Linda Rymarquis, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang
  • Publication number: 20190300890
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Application
    Filed: March 29, 2019
    Publication date: October 3, 2019
    Applicant: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Publication number: 20190218563
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 18, 2019
    Applicant: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Patent number: 10294486
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: May 21, 2019
    Assignee: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma
  • Publication number: 20180105819
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.
    Type: Application
    Filed: October 18, 2017
    Publication date: April 19, 2018
    Inventors: Brent BROWER-TOLAND, Shunhong DAI, Karen GABBERT, Alexander GOLDSHMIDT, Miya HOWELL, Brad MCDILL, Dan OVADYA, Beth SAVIDGE, Vijay SHARMA
  • Publication number: 20180051295
    Abstract: The present disclosure provides compositions and methods for altering gibberellin (GA) content in corn or other cereal plants. Methods and compositions are also provided for altering the expression of genes related to gibberellin biosynthesis through suppression, mutagenesis and/or editing of specific subtypes of GA20 or GA3 oxidase genes. Modified plant cells and plants having a suppression element or mutation reducing the expression or activity of a GA oxidase gene are further provided comprising reduced gibberellin levels and improved characteristics, such as reduced plant height and increased lodging resistance, but without off-types.
    Type: Application
    Filed: August 17, 2017
    Publication date: February 22, 2018
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: Edwards M. Allen, Jayanand Boddu, Charles R. Dietrich, Alexander Goldshmidt, Miya Howell, Kevin R. Kosola, Anil Neelam, Thomas L. Slewinski, Tyamagondlu V. Venkatesh, Huai Wang
  • Publication number: 20160304891
    Abstract: The present invention provides recombinant DNA constructs, vectors and molecules comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a vegetative stage promoter, which may also be a meristem-preferred or meristem-specific promoter. Transgenic plants, plant cells and tissues, and plant parts are further provided comprising a polynucleotide sequence encoding a florigenic FT protein. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant, particularly on the main stem of the plant, relative to a control or wild type plant. Methods are further provided for introducing a florigenic FT transgene into a plant, and planting transgenic FT plants in the field including at higher densities. Transgenic plants of the present invention may thus provide greater yield potential than wild type plants and may be planted at a higher density due to their altered plant architecture.
    Type: Application
    Filed: April 18, 2016
    Publication date: October 20, 2016
    Applicant: Monsanto Technology LLC
    Inventors: Brent Brower-Toland, Rico A. Caldo, Shunhong Dai, Karen Gabbert, Alexander Goldshmidt, Miya D. Howell, Balasulojini Karunanandaa, Sivalinganna Manjunath, Bradley W. McDill, Daniel J. Ovadya, Sasha Preuss, Elena A. Rice, Beth Savidge, Vijay K. Sharma